Exelixis | Omsætningsaktiver



Current Assets Lave om Dato
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Bayer EUR 34.44B 1.31B 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Cytokinetics USD 1.11B 89.34M 2024-12
Eisai JPY 761.1B 79.19B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Exelixis USD 1.47B 82.14M 2025-01
Genmab DKK 27.85B 4.16B 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 38.78B 1.58B 2024-12
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Sanofi 42.59B 12.51B 2024-12
Takeda JPY 2.75T 299.73B 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Xencor USD 577.6M 4.27M 2024-12



Exelixis Omsætningsaktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.